Connor, Clark & Lunn Investment Management Ltd. Pacific Biosciences Of California, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $21.8 Billion
- Q1 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 148,046 shares of PACB stock, worth $189,498. This represents 0.0% of its overall portfolio holdings.
Number of Shares
148,046Holding current value
$189,498% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding PACB
# of Institutions
293Shares Held
253MCall Options Held
1.42MPut Options Held
1.18M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.3MShares$42.6 Million0.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA26.6MShares$34.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY23.4MShares$29.9 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA17.6MShares$22.5 Million9.04% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.12.8MShares$16.4 Million0.03% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $288M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...